checkAd
    Startseite > Aktien > Spago Nanomedical > Nachrichten
    Spago Nanomedical Aktie
    0,0268
     
    EUR
    -4,96 %
    -0,0014 EUR
    Letzter Kurs 09:59:02 Frankfurt
    0,0278
     
    EUR
    71.943 STK
    Geldkurs 17:11:59
    0,0338
     
    EUR
    59.172 STK
    Briefkurs 15:52:18
    ISIN: SE0004899474 · WKN: A1J8G8 · SYM: 7UX · Schweden

    Neueste Nachrichten

    Spago Nanomedical Interim Report January-March 2024
    08:50 Uhr · Accesswire · Spago Nanomedical
    Spago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad
    24.04.24 · Accesswire · Spago Nanomedical
    Spago Nanomedical Strengthens Management with Head of CMC & Supply
    16.04.24 · Accesswire · Spago Nanomedical
    Spago Nanomedical Reports Positive Top Line Data from Clinical Phase IIa Study SPAGOPIX-02 In Patients with Endometriosis
    15.12.23 · Accesswire · Spago Nanomedical
    First Patient Dosed in Spago Nanomedical's Clinical Phase I/IIa Study within the Tumorad(R) Program
    07.12.23 · Accesswire · Spago Nanomedical
    Last Day of the Subscription Period in Spago Nanomedical’s Rights Issue
    23.11.23 · Accesswire · Spago Nanomedical
    Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2024
    14.11.23 · Accesswire · Spago Nanomedical
    The Subscription Period in Spago Nanomedical’s Rights Issue Begins Today
    09.11.23 · Accesswire · Spago Nanomedical
    Spago Nanomedical Interim Report January-September 2023
    03.11.23 · Accesswire · Spago Nanomedical
    Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB on 31 October 2023
    31.10.23 · Accesswire · Spago Nanomedical
    Spago Nanomedical applies for extended patent protection for Tumorad(R)
    24.10.23 · Accesswire · Spago Nanomedical
    Spago Nanomedical Receives Approval to Initiate the Clinical Phase I/IIa study with Tumorad(R) in Australia
    19.10.23 · Accesswire · Spago Nanomedical